JOHN S MCMURRAY

TitleAssociate Professor
InstitutionMD Anderson
DepartmentExperimental Therapeutics
Address1901 East Road
Houston TX 77054-3005
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Sun G, Yafasova A, Andersson C, McMurray JJV, Jhund PS, Docherty KF, Faurschou M, Nielsen CT, Schou M, Gislason GH, Torp-Pedersen C, Fosbøl EL, Køber L, Butt JH. Gender- and Age-Specific Rates of Heart Failure and other Adverse Cardiovascular Outcomes in Systemic Sclerosis. Rheumatology (Oxford). 2022 Feb 08. PMID: 35136973.
      Citations:    Fields:    
    2. Yafasova A, Fosbøl EL, Schou M, Baslund B, Faurschou M, Docherty KF, Jhund PS, McMurray JJV, Sun G, Kristensen SL, Torp-Pedersen C, Køber L, Butt JH. Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus. J Am Coll Cardiol. 2021 04 13; 77(14):1717-1727. PMID: 33832598.
      Citations: 3     Fields:    Translation:Humans
    3. Knight JM, Mandal P, Morlacchi P, Mak G, Li E, Madison M, Landers C, Saxton B, Felix E, Gilbert B, Sederstrom J, Varadhachary A, Singh MM, Chatterjee D, Corry DB, McMurray JS. Small molecule targeting of the STAT5/6 Src homology 2 (SH2) domains to inhibit allergic airway disease. J Biol Chem. 2018 06 29; 293(26):10026-10040. PMID: 29739850.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    4. Rahal OM, Wolfe AR, Mandal PK, Larson R, Tin S, Jimenez C, Zhang D, Horton J, Reuben JM, McMurray JS, Woodward WA. Blocking Interleukin (IL)4- and IL13-Mediated Phosphorylation of STAT6 (Tyr641) Decreases M2 Polarization of Macrophages and Protects Against Macrophage-Mediated Radioresistance of Inflammatory Breast Cancer. Int J Radiat Oncol Biol Phys. 2018 03 15; 100(4):1034-1043. PMID: 29485045.
      Citations: 42     Fields:    Translation:HumansCells
    5. Chen J, Raju GS, Jogunoori W, Menon V, Majumdar A, Chen JS, Gi YJ, Jeong YS, Phan L, Belkin M, Gu S, Kundra S, Mistry NA, Zhang J, Su X, Li S, Lin SH, Javle M, McMurray JS, Rahlfs TF, Mishra B, White J, Rashid A, Beauchemin N, Weston BR, Shafi MA, Stroehlein JR, Davila M, Akbani R, Weinstein JN, Wu X, Mishra L. Mutational Profiles Reveal an Aberrant TGF-ß-CEA Regulated Pathway in Colon Adenomas. PLoS One. 2016; 11(4):e0153933. PMID: 27100181.
      Citations: 10     Fields:    Translation:HumansCells
    6. Sarkar A, Balakrishnan K, Chen J, Patel V, Neelapu SS, McMurray JS, Gandhi V. Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma. Oncotarget. 2016 Jan 19; 7(3):3461-76. PMID: 26658105.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    7. Knight JM, Mak G, Shaw J, Porter P, McDermott C, Roberts L, You R, Yuan X, Millien VO, Qian Y, Song LZ, Frazier V, Kim C, Kim JJ, Bond RA, Milner JD, Zhang Y, Mandal PK, Luong A, Kheradmand F, McMurray JS, Corry DB. Long-Acting Beta Agonists Enhance Allergic Airway Disease. PLoS One. 2015; 10(11):e0142212. PMID: 26605551.
      Citations: 6     Fields:    Translation:HumansAnimals
    8. Mandal PK, Morlacchi P, Knight JM, Link TM, Lee GR, Nurieva R, Singh D, Dhanik A, Kavraki L, Corry DB, Ladbury JE, McMurray JS. Targeting the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 6 (STAT6) with Cell-Permeable, Phosphatase-Stable Phosphopeptide Mimics Potently Inhibits Tyr641 Phosphorylation and Transcriptional Activity. J Med Chem. 2015 Nov 25; 58(22):8970-84. PMID: 26506089.
      Citations: 14     Fields:    Translation:AnimalsCells
    9. Sahoo A, Alekseev A, Tanaka K, Obertas L, Lerman B, Haymaker C, Clise-Dwyer K, McMurray JS, Nurieva R. Batf is important for IL-4 expression in T follicular helper cells. Nat Commun. 2015 Aug 17; 6:7997. PMID: 26278622.
      Citations: 44     Fields:    Translation:AnimalsCells
    10. Zhang H, Hu H, Greeley N, Jin J, Matthews AJ, Ohashi E, Caetano MS, Li HS, Wu X, Mandal PK, McMurray JS, Moghaddam SJ, Sun SC, Watowich SS. STAT3 restrains RANK- and TLR4-mediated signalling by suppressing expression of the E2 ubiquitin-conjugating enzyme Ubc13. Nat Commun. 2014 Dec 15; 5:5798. PMID: 25503582.
      Citations: 32     Fields:    Translation:HumansAnimalsCells
    11. Mandal PK, Birtwistle JS, McMurray JS. Hydrodehalogenation of alkyl iodides with base-mediated hydrogenation and catalytic transfer hydrogenation: application to the asymmetric synthesis of N-protected a-methylamines. J Org Chem. 2014 Sep 05; 79(17):8422-7. PMID: 25116734.
      Citations: 2     Fields:    Translation:Cells
    12. Schoberle TJ, Nguyen-Coleman CK, Herold J, Yang A, Weirauch M, Hughes TR, McMurray JS, May GS. A novel C2H2 transcription factor that regulates gliA expression interdependently with GliZ in Aspergillus fumigatus. PLoS Genet. 2014 May; 10(5):e1004336. PMID: 24784729.
      Citations: 13     Fields:    Translation:AnimalsCells
    13. Baameur F, Hammitt RA, Friedman J, McMurray JS, Clark RB. Biochemical and Cellular Specificity of Peptide Inhibitors of G Protein-Coupled Receptor Kinases. Int J Pept Res Ther. 2014 Mar; 20(1):1-12. PMID: 25530741.
      Citations: 6     
    14. Morlacchi P, Robertson FM, Klostergaard J, McMurray JS. Targeting SH2 domains in breast cancer. Future Med Chem. 2014; 6(17):1909-26. PMID: 25495984.
      Citations: 26     Fields:    Translation:HumansCells
    15. Morlacchi P, Mandal PK, McMurray JS. Synthesis and in Vitro Evaluation of a Peptidomimetic Inhibitor Targeting the Src Homology 2 (SH2) Domain of STAT6. ACS Med Chem Lett. 2014 Jan 09; 5(1):69-72. PMID: 24900775.
      Citations: 5     
    16. Dhanik A, McMurray JS, Kavraki LE. DINC: a new AutoDock-based protocol for docking large ligands. BMC Struct Biol. 2013; 13 Suppl 1:S11. PMID: 24564952.
      Citations: 11     Fields:    Translation:Cells
    17. Xu W, Lacerda L, Debeb BG, Atkinson RL, Solley TN, Li L, Orton D, McMurray JS, Hang BI, Lee E, Klopp AH, Ueno NT, Reuben JM, Krishnamurthy S, Woodward WA. The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer. PLoS One. 2013; 8(8):e71508. PMID: 24013655.
      Citations: 21     Fields:    Translation:HumansAnimalsCells
    18. Mandal PK, Ren Z, Chen X, Kaluarachchi K, Liao WS, McMurray JS. Structure-Activity Studies of Phosphopeptidomimetic Prodrugs Targeting the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 3 (Stat3). Int J Pept Res Ther. 2013 Mar; 19(1):3-12. PMID: 24707243.
      Citations: 5     
    19. Kannan S, Sutphin RM, Hall MG, Golfman LS, Fang W, Nolo RM, Akers LJ, Hammitt RA, McMurray JS, Kornblau SM, Melnick AM, Figueroa ME, Zweidler-McKay PA. Notch activation inhibits AML growth and survival: a potential therapeutic approach. J Exp Med. 2013 Feb 11; 210(2):321-37. PMID: 23359069.
      Citations: 74     Fields:    Translation:HumansAnimalsCells
    20. Dhanik A, McMurray JS, Kavraki LE. Binding modes of peptidomimetics designed to inhibit STAT3. PLoS One. 2012; 7(12):e51603. PMID: 23251591.
      Citations: 11     Fields:    Translation:HumansCells
    21. McMurray JS, Mandal PK, Liao WS, Klostergaard J, Robertson FM. The consequences of selective inhibition of signal transducer and activator of transcription 3 (STAT3) tyrosine705 phosphorylation by phosphopeptide mimetic prodrugs targeting the Src homology 2 (SH2) domain. JAKSTAT. 2012 Oct 01; 1(4):263-347. PMID: 24058783.
      Citations: 12     
    22. Auzenne EJ, Klostergaard J, Mandal PK, Liao WS, Lu Z, Gao F, Bast RC, Robertson FM, McMurray JS. A phosphopeptide mimetic prodrug targeting the SH2 domain of Stat3 inhibits tumor growth and angiogenesis. J Exp Ther Oncol. 2012; 10(2):155-62. PMID: 23350355.
      Citations: 23     Fields:    Translation:HumansAnimalsCells
    23. Mandal PK, Freiter EM, Bagsby AL, Robertson FM, McMurray JS. Efficient synthesis of apricoxib, CS-706, a selective cyclooxygenase-2 inhibitor, and evaluation of inhibition of prostaglandin E2 production in inflammatory breast cancer cells. Bioorg Med Chem Lett. 2011 Oct 15; 21(20):6071-3. PMID: 21903394.
      Citations: 3     Fields:    Translation:HumansCells
    24. Mandal PK, Gao F, Lu Z, Ren Z, Ramesh R, Birtwistle JS, Kaluarachchi KK, Chen X, Bast RC, Liao WS, McMurray JS. Potent and selective phosphopeptide mimetic prodrugs targeted to the Src homology 2 (SH2) domain of signal transducer and activator of transcription 3. J Med Chem. 2011 May 26; 54(10):3549-63. PMID: 21486047.
      Citations: 49     Fields:    Translation:HumansCells
    25. Dhanik A, McMurray JS, Kavraki L. On modeling peptidomimetics in complex with the SH2 domain of Stat3. Annu Int Conf IEEE Eng Med Biol Soc. 2011; 2011:3229-32. PMID: 22255027.
      Citations: 2     Fields:    Translation:Cells
    26. Robertson FM, Simeone AM, Lucci A, McMurray JS, Ghosh S, Cristofanilli M. Differential regulation of the aggressive phenotype of inflammatory breast cancer cells by prostanoid receptors EP3 and EP4. Cancer. 2010 Jun 01; 116(11 Suppl):2806-14. PMID: 20503412.
      Citations: 23     Fields:    Translation:HumansCells
    27. Baameur F, Morgan DH, Yao H, Tran TM, Hammitt RA, Sabui S, McMurray JS, Lichtarge O, Clark RB. Role for the regulator of G-protein signaling homology domain of G protein-coupled receptor kinases 5 and 6 in beta 2-adrenergic receptor and rhodopsin phosphorylation. Mol Pharmacol. 2010 Mar; 77(3):405-15. PMID: 20038610.
      Citations: 35     Fields:    Translation:HumansCells
    28. Mandal PK, Ren Z, Chen X, Xiong C, McMurray JS. Structure-affinity relationships of glutamine mimics incorporated into phosphopeptides targeted to the SH2 domain of signal transducer and activator of transcription 3. J Med Chem. 2009 Oct 08; 52(19):6126-41. PMID: 19728728.
      Citations: 16     Fields:    Translation:HumansAnimalsCells
    29. Mandal PK, Liao WS, McMurray JS. Synthesis of phosphatase-stable, cell-permeable peptidomimetic prodrugs that target the SH2 domain of Stat3. Org Lett. 2009 Aug 06; 11(15):3394-7. PMID: 19594124.
      Citations: 30     Fields:    Translation:HumansCells
    30. Lu M, Yang J, Ren Z, Sabui S, Espejo A, Bedford MT, Jacobson RH, Jeruzalmi D, McMurray JS, Chen X. Crystal structure of the three tandem FF domains of the transcription elongation regulator CA150. J Mol Biol. 2009 Oct 23; 393(2):397-408. PMID: 19660470.
      Citations: 5     Fields:    Translation:HumansCells
    31. Mandal PK, Limbrick D, Coleman DR, Dyer GA, Ren Z, Birtwistle JS, Xiong C, Chen X, Briggs JM, McMurray JS. Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modeling. J Med Chem. 2009 Apr 23; 52(8):2429-42. PMID: 19334714.
      Citations: 24     Fields:    Translation:Cells
    32. McMurray JS, Mandal PK, Liao WS, Ren Z, Chen X. Inhibition of Stat3 by cell-permeable peptidomimetic prodrugs targeted to its SH2 domain. Adv Exp Med Biol. 2009; 611:545-6. PMID: 19400306.
      Citations: 4     Fields:    Translation:HumansCells
    33. McMurray JS, Ren Z, Mandal PK, Chen X. Model of intermolecular interactions between high affinity phosphopeptides and Stat3. Adv Exp Med Biol. 2009; 611:543-4. PMID: 19400305.
      Citations: 1     Fields:    Translation:Cells
    34. Mandal PK, McMurray JS. Application of triethylsilane and palladium-charcoal-induced reductions in the synthesis of Fmoc-glutamic acid analogues. Adv Exp Med Biol. 2009; 611:181-2. PMID: 19400150.
      Citations: 1     Fields:    Translation:Cells
    35. Ren Z, Mao X, Mertens C, Krishnaraj R, Qin J, Mandal PK, Romanowski MJ, McMurray JS, Chen X. Crystal structure of unphosphorylated STAT3 core fragment. Biochem Biophys Res Commun. 2008 Sep 12; 374(1):1-5. PMID: 18433722.
      Citations: 41     Fields:    Translation:AnimalsCells
    36. Robertson FM, Simeone AM, Mazumdar A, Shah AH, McMurray JS, Ghosh S, Cristofanilli M. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells. J Exp Ther Oncol. 2008; 7(4):299-312. PMID: 19227010.
      Citations: 21     Fields:    Translation:HumansCells
    37. McMurray JS. Structural basis for the binding of high affinity phosphopeptides to Stat3. Biopolymers. 2008; 90(1):69-79. PMID: 18058821.
      Citations: 16     Fields:    Translation:HumansCells
    38. Mandal PK, McMurray JS. Pd-C-induced catalytic transfer hydrogenation with triethylsilane. J Org Chem. 2007 Aug 17; 72(17):6599-601. PMID: 17630799.
      Citations: 23     Fields:    Translation:Cells
    39. Mandal PK, Heard PA, Ren Z, Chen X, McMurray JS. Solid-phase synthesis of Stat3 inhibitors incorporating O-carbamoylserine and O-carbamoylthreonine as glutamine mimics. Bioorg Med Chem Lett. 2007 Feb 01; 17(3):654-6. PMID: 17113289.
      Citations: 15     Fields:    Translation:Cells
    40. McMurray JS. A new small-molecule Stat3 inhibitor. Chem Biol. 2006 Nov; 13(11):1123-4. PMID: 17113993.
      Citations: 38     Fields:    Translation:Cells
    41. Mandal PK, Kaluarachchi KK, Ogrin D, Bott SG, McMurray JS. An efficient synthesis of the constrained peptidomimetic 2-oxo-3-(N-9-fluorenyloxycarbonylamino)-1-azabicyclo[4.3.0]nonane-9-carboxylic acid from pyroglutamic acid. J Org Chem. 2005 Nov 25; 70(24):10128-31. PMID: 16292854.
      Citations: 2     Fields:    Translation:Cells
    42. Coleman DR, Ren Z, Mandal PK, Cameron AG, Dyer GA, Muranjan S, Campbell M, Chen X, McMurray JS. Investigation of the binding determinants of phosphopeptides targeted to the SRC homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor. J Med Chem. 2005 Oct 20; 48(21):6661-70. PMID: 16220982.
      Citations: 43     Fields:    Translation:Cells
    43. Wang W, McMurray JS, Wu Q, Campbell ML, Li C. Convenient solid-phase synthesis of diethylenetriaminepenta-acetic acid (DTPA)- conjugated cyclic RGD peptide analogues. Cancer Biother Radiopharm. 2005 Oct; 20(5):547-56. PMID: 16248770.
      Citations: 4     Fields:    Translation:HumansAnimalsCells
    44. Wang W, Wu Q, Pasuelo M, McMurray JS, Li C. Probing for integrin alpha v beta3 binding of RGD peptides using fluorescence polarization. Bioconjug Chem. 2005 May-Jun; 16(3):729-34. PMID: 15898744.
      Citations: 15     Fields:    Translation:HumansCells
    45. Mao X, Ren Z, Parker GN, Sondermann H, Pastorello MA, Wang W, McMurray JS, Demeler B, Darnell JE, Chen X. Structural bases of unphosphorylated STAT1 association and receptor binding. Mol Cell. 2005 Mar 18; 17(6):761-71. PMID: 15780933.
      Citations: 113     Fields:    Translation:HumansCells
    46. Conrad C, Miller CR, Ji Y, Gomez-Manzano C, Bharara S, McMurray JS, Lang FF, Wong F, Sawaya R, Yung WK, Fueyo J. Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization. Cancer Gene Ther. 2005 Mar; 12(3):284-94. PMID: 15650766.
      Citations: 21     Fields:    Translation:HumansAnimalsCells
    47. Aguilar D, Solomon SD, Køber L, Rouleau JL, Skali H, McMurray JJ, Francis GS, Henis M, O'Connor CM, Diaz R, Belenkov YN, Varshavsky S, Leimberger JD, Velazquez EJ, Califf RM, Pfeffer MA. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Circulation. 2004 Sep 21; 110(12):1572-8. PMID: 15364810.
      Citations: 51     Fields:    Translation:Humans
    48. Lu Y, Yu Q, Liu JH, Zhang J, Wang H, Koul D, McMurray JS, Fang X, Yung WK, Siminovitch KA, Mills GB. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades. J Biol Chem. 2003 Oct 10; 278(41):40057-66. PMID: 12869565.
      Citations: 91     Fields:    Translation:HumansAnimalsCells
    49. Ren Z, Cabell LA, Schaefer TS, McMurray JS. Identification of a high-affinity phosphopeptide inhibitor of Stat3. Bioorg Med Chem Lett. 2003 Feb 24; 13(4):633-6. PMID: 12639546.
      Citations: 50     Fields:    Translation:HumansCells
    50. Burke TR, Yao ZJ, Liu DG, Voigt J, Gao Y. Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors. Biopolymers. 2001; 60(1):32-44. PMID: 11376431.
      Citations: 16     Fields:    Translation:Cells
    51. McMurray JS, Coleman DR, Wang W, Campbell ML. The synthesis of phosphopeptides. Biopolymers. 2001; 60(1):3-31. PMID: 11376430.
      Citations: 10     Fields:    Translation:Cells
    52. Wang W, Ramdas L, Sun G, Ke S, Obeyesekere NU, Budde RJ, McMurray JS. Cyclic peptides incorporating 4-carboxyphenylalanine and phosphotyrosine are potent inhibitors of pp60(c-)(src). Biochemistry. 2000 May 02; 39(17):5221-8. PMID: 10819990.
      Citations: 1     Fields:    Translation:Animals
    53. Ramdas L, Obeyesekere NU, Sun G, McMurray JS, Budde RJ. N-myristoylation of a peptide substrate for Src converts it into an apparent slow-binding bisubstrate-type inhibitor. J Pept Res. 1999 May; 53(5):569-77. PMID: 10424353.
      Citations:    Fields:    Translation:Cells
    54. Bonewald LF, Bibbs L, Kates SA, Khatri A, McMurray JS, Medzihradszky KF, Weintraub ST. Study on the synthesis and characterization of peptides containing phosphorylated tyrosine. J Pept Res. 1999 Feb; 53(2):161-9. PMID: 10195453.
      Citations: 2     Fields:    
    55. Schilling B, Wang W, McMurray JS, Medzihradszky KF. Fragmentation and sequencing of cyclic peptides by matrix-assisted laser desorption/ionization post-source decay mass spectrometry. Rapid Commun Mass Spectrom. 1999; 13(21):2174-9. PMID: 10523777.
      Citations: 8     Fields:    
    56. McMurray JS, Budde RJ, Ke S, Obeyesekere NU, Wang W, Ramdas L, Lewis CA. Cyclic peptides as probes of the substrate binding site of the cytosolic tyrosine kinase, pp60c-src. Arch Biochem Biophys. 1998 Jul 01; 355(1):124-30. PMID: 9647675.
      Citations: 2     Fields:    Translation:AnimalsCells
    57. McMurray JS. The use of polyacrylamide-based peptide synthesis resins for the generation of antipeptide antibodies. Biopolymers. 1998; 47(5):405-11. PMID: 9973868.
      Citations:    Fields:    Translation:HumansAnimalsCells
    58. Nishi T, Budde RJ, McMurray JS, Obeyesekere NU, Safdar N, Levin VA, Saya H. Tight-binding inhibitory sequences against pp60(c-src) identified using a random 15-amino-acid peptide library. FEBS Lett. 1996 Dec 16; 399(3):237-40. PMID: 8985153.
      Citations: 4     Fields:    Translation:Cells
    59. Ramdas L, Obeyesekere NU, McMurray JS, Budde RJ. A synthetic peptidic substrate of minimal size and semioptimal sequence for the protein tyrosine kinase pp60c-src. Arch Biochem Biophys. 1996 Feb 01; 326(1):73-8. PMID: 8579374.
      Citations:    Fields:    Translation:HumansCells
    60. Ramdas L, Obeyesekere NU, McMurray JS, Gallick GE, Seifert WE, Budde RJ. A tyrphostin-derived inhibitor of protein tyrosine kinases: isolation and characterization. Arch Biochem Biophys. 1995 Nov 10; 323(2):237-42. PMID: 7487083.
      Citations:    Fields:    Translation:HumansCells
    61. Budde RJ, Obeyesekere NU, Ke S, McMurray JS. Use of synthetic peptides and copolymers to study the substrate specificity and inhibition of the protein tyrosine kinase pp60c-src. Biochim Biophys Acta. 1995 Apr 05; 1248(1):50-6. PMID: 7536039.
      Citations: 3     Fields:    Translation:Cells
    62. McMurray JS, Lewis CA, Obeyesekere NU. Influence of solid support, solvent and coupling reagent on the head-to-tail cyclization of resin-bound peptides. Pept Res. 1994 Jul-Aug; 7(4):195-206. PMID: 7696839.
      Citations: 3     Fields:    Translation:Cells
    63. Ramdas L, McMurray JS, Budde RJ. The degree of inhibition of protein tyrosine kinase activity by tyrphostin 23 and 25 is related to their instability. Cancer Res. 1994 Feb 15; 54(4):867-9. PMID: 7508821.
      Citations: 6     Fields:    
    64. Obeyesekere NU, La Croix JN, Budde RJ, Dyckes DF, McMurray JS. Solid-phase synthesis of (tyrosyl-alanyl-glutamyl)n by segment condensation. Int J Pept Protein Res. 1994 Feb; 43(2):118-26. PMID: 8200729.
      Citations:    Fields:    Translation:Cells
    65. McMurray JS, Budde RJ, Dyckes DF. Cyclic peptide substrates of pp60c-src. Synthesis and evaluation. Int J Pept Protein Res. 1993 Sep; 42(3):209-15. PMID: 7693604.
      Citations: 2     Fields:    Translation:Cells
    66. Budde RJ, McMurray JS, Tinker DA. An assay for acidic peptide substrates of protein kinases. Anal Biochem. 1992 Feb 01; 200(2):347-51. PMID: 1378706.
      Citations: 1     Fields:    Translation:AnimalsCells
    67. Tinker DA, Cartron JL, McMurray JS, Levin VA. Influence of acidic residues on substrate specificity of oncogene products pp60v-src and p56lck in vitro. Anticancer Res. 1992 Jan-Feb; 12(1):123-7. PMID: 1567157.
      Citations:    Fields:    Translation:AnimalsCells
    68. McMurray JS, Dyckes DF. Evidence for hemiketals as intermediates in the inactivation of serine proteinases with halomethyl ketones. Biochemistry. 1986 Apr 22; 25(8):2298-301. PMID: 3518799.
      Citations: 3     Fields:    Translation:Cells
    69. A solubilisable polymer support suitable for solid phase peptide synthesis and for injection into experimental animals. Journal of the Chemical Society, Chemical Communications. 1025-1027.
    70. Batf is important for IL-4 expression in T follicular helper cells. Nature Communications. 6.
    71. On modeling peptidomimetics in complex with the SH2 domain of Stat3. 3229-3232.
    72. STAT3 signaling in cancer. 216-267.
    73. The synthesis of cyclic peptides using fmoc solid-phase chemistry and the linkage agent 4-(4-Hydroxymethyl-3-methoxyphenoxy)-butyric acid. Tetrahedron Letters. 34:8059-8062.
    74. A simple and convenient method for the preparation of ketomethylene peptide analogues. Journal of Organic Chemistry. 50:1112-1115.
    75. Discovery, development, and testing of substrates and inhibitors of pp60(c-src). International Journal of Pharmacognosy. 33:27-34.
    76. A selective method for the preparation of primary amides. Tetrahedron Letters. 40:2501-2504.
    77. Discovery, development, and testing of substrates and inhibitors of pp60c-SRC . Pharmaceutical Biology. 33:27-34.
    78. Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma. Oncotarget. 7:3461-3476.
    79. Analysis of racemization during "Standard" solid phase peptide synthesis. Techniques in Protein Chemistry. 8:875-890.
    80. Tuftsin and tuftsin analogs. Current Medicinal Chemistry. 3:153-166.
    81. Formation of a disulfide bond in an octreotide-like peptide. Techniques in Protein Chemistry. 7:261-274.
    82. Solid phase synthesis of a cyclic peptide using fmoc chemistry. Tetrahedron Letters. 32:7679-7682.
    83. Convenient preparation of 4-(tetrazol-5-yl)-phenylalanine for use in Fmoc-based solid-phase peptide synthesis. Tetrahedron Letters. 41:6555-6558.
    84. Structure-activity studies of phosphopeptidomimetic prodrugs targeting the src homology 2 (SH2) domain of signal transducer and activator of transcription 3 (Stat3). International Journal of Peptide Research and Therapeutics. 19:3-12.
    85. Tetrahedron Letters. 46:3715-3718.
    86. Biochemical and cellular specificity of peptide inhibitors of g protein-coupled receptor kinases. International Journal of Peptide Research and Therapeutics. 20:1-12.
    87. Solid phase synthesis of phosphopeptides incorporating 2,2- dimethyloxazolidine pseudoproline analogs. International Journal of Peptide Research and Therapeutics. 14:1-9.
    88. Evidence for hemiketals as intermediates in the inactivation of serine proteinases with halomethyl ketones. Biochemistry. 25:2293-2298.
    89. Long-acting beta agonists enhance allergic airway disease. PLoS One. 10.
    90. Two-carbon ring expansion of β-lactams via N(1)-C(4) cleavage reactions. Tetrahedron Letters. 43:2491-2493.
    91. Editorial. Biopolymers - Peptide Science Section. 60:1-2.
    92. Stereospecific synthesis of 4-carboxyphenylalanine and derivatives for use in Fmoc-based solid-phase peptide synthesis. Tetrahedron Letters. 37:6661-6664.
    93. Synthesis and in vitro evaluation of a peptidomimetic inhibitor targeting the Src Homology 2 (SH2) domain of STAT6. ACS Medicinal Chemistry Letters. 5:69-72.
    94. Mutational profiles reveal an aberrant TGF-β-CEA regulated pathway in colon adenomas. PLoS One. 11.
    95. Tetrahedron Letters. 42:8409-8413.
    96. Auto dock-based incremental docking protocol to improve docking of large ligands. 48-55.
    MCMURRAY's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (391)
    Explore
    _
    Co-Authors (51)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _